Literature DB >> 19444074

HIV infection and the risk of diabetes mellitus.

Adeel A Butt1, Kathleen McGinnis, Maria C Rodriguez-Barradas, Stephen Crystal, Michael Simberkoff, Matthew Bidwell Goetz, David Leaf, Amy C Justice.   

Abstract

BACKGROUND: The influence of HIV infection on the risk of diabetes is unclear. We determined the association and predictors of prevalent diabetes mellitus in HIV infected and uninfected veterans.
METHODS: We determined baseline prevalence and risk factors for diabetes between HIV infected and uninfected veterans in the Veterans Aging Cohort Study. Logistic regression was used to determine the odds of diabetes in HIV infected and uninfected persons.
RESULTS: We studied 3227 HIV-infected and 3240 HIV-uninfected individuals. HIV-infected individuals were younger, more likely to be black males, have HCV coinfection and a lower BMI. HIV-infected individuals had a lower prevalence of diabetes at baseline (14.9 vs. 21.4%, P < 0.0001). After adjustment for known risk factors, HIV-infected individuals had a lower risk of diabetes (odds ratio = 0.84, 95% confidence interval = 0.72-0.97). Increasing age, male sex, minority race, and BMI were associated with an increased risk. The odds ratio for diabetes associated with increasing age, minority race and BMI were greater among HIV-infected veterans. HCV coinfection and nucleoside and nonnucleoside reverse transcriptase inhibitor therapy were associated with a higher risk of diabetes in HIV-infected veterans.
CONCLUSION: Although HIV infection itself is not associated with increased risk of diabetes, increasing age; HCV coinfection and BMI have a more profound effect upon the risk of diabetes among HIV-infected persons. Further, long-term ARV treatment also increases risk. Future studies will need to determine whether incidence of diabetes mellitus differs by HIV status.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19444074      PMCID: PMC2752953          DOI: 10.1097/QAD.0b013e32832bd7af

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  29 in total

1.  Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: A case-control study.

Authors:  Albert Lecube; Cristina Hernández; Joan Genescà; Rafael Simó
Journal:  Diabetes Care       Date:  2006-05       Impact factor: 19.112

2.  Relative prevalence of comorbidities and treatment contraindications in HIV-mono-infected and HIV/HCV-co-infected veterans.

Authors:  Joseph L Goulet; Shawn L Fultz; Kathleen A McGinnis; Amy C Justice
Journal:  AIDS       Date:  2005-10       Impact factor: 4.177

3.  Mitochondrial dysfunction and type 2 diabetes.

Authors:  Bradford B Lowell; Gerald I Shulman
Journal:  Science       Date:  2005-01-21       Impact factor: 47.728

4.  The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test.

Authors:  K Bush; D R Kivlahan; M B McDonell; S D Fihn; K A Bradley
Journal:  Arch Intern Med       Date:  1998-09-14

5.  Prevalence of diabetes mellitus and dyslipidemia among antiretroviral naive patients co-infected with hepatitis C virus (HCV) and HIV-1 compared to patients without co-infection.

Authors:  Fehmida Visnegarwala; Li Chen; Subha Raghavan; Ellen Tedaldi
Journal:  J Infect       Date:  2005-05       Impact factor: 6.072

6.  Case-control study of diabetes mellitus in HIV-infected patients.

Authors:  Cecilia Yoon; Roy M Gulick; Donald R Hoover; Carlos M Vaamonde; Marshall J Glesby
Journal:  J Acquir Immune Defic Syndr       Date:  2004-12-01       Impact factor: 3.731

7.  Insulin resistance in chronic hepatitis C.

Authors:  G Yazicioglu; F Isitan; H Altunbas; I Suleymanlar; M Ozdogan; M K Balci; U Karayalcin
Journal:  Int J Clin Pract       Date:  2004-11       Impact factor: 2.503

8.  Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study.

Authors:  Todd T Brown; Stephen R Cole; Xiuhong Li; Lawrence A Kingsley; Frank J Palella; Sharon A Riddler; Barbara R Visscher; Joseph B Margolick; Adrian S Dobs
Journal:  Arch Intern Med       Date:  2005-05-23

9.  Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study.

Authors:  Todd T Brown; Xiuhong Li; Stephen R Cole; Lawrence A Kingsley; Frank J Palella; Sharon A Riddler; Joan S Chmiel; Barbara R Visscher; Joseph B Margolick; Adrian S Dobs
Journal:  AIDS       Date:  2005-09-02       Impact factor: 4.177

10.  Relationship between hepatitis C virus (HCV) and insulin resistance, endothelial perturbation, and platelet activation in HIV-HCV-coinfected patients under highly active antiretroviral treatment.

Authors:  G F de Larrañaga; S D A Perés Wingeyer; L M Puga; B S Alonso; J A Benetucci
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-02       Impact factor: 3.267

View more
  144 in total

1.  Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart disease.

Authors:  Adeel A Butt; Chung-Chou Chang; Lewis Kuller; Matthew Bidwell Goetz; David Leaf; David Rimland; Cynthia L Gibert; Krisann K Oursler; Maria C Rodriguez-Barradas; Joseph Lim; Lewis E Kazis; Stephen Gottlieb; Amy C Justice; Matthew S Freiberg
Journal:  Arch Intern Med       Date:  2011-04-25

2.  Risk of type 2 diabetes among HIV-infected and healthy subjects in Italy.

Authors:  Laura Galli; Stefania Salpietro; Gabriele Pellicciotta; Alberto Galliani; Piermarco Piatti; Hamid Hasson; Monica Guffanti; Nicola Gianotti; Alba Bigoloni; Adriano Lazzarin; Antonella Castagna
Journal:  Eur J Epidemiol       Date:  2012-06-22       Impact factor: 8.082

3.  Association of HIV, hepatitis C virus and liver fibrosis severity with interleukin-6 and C-reactive protein levels.

Authors:  Shailja Shah; Yifei Ma; Rebecca Scherzer; Greg Huhn; Audrey L French; Michael Plankey; Marion G Peters; Carl Grunfeld; Phyllis C Tien
Journal:  AIDS       Date:  2015-07-17       Impact factor: 4.177

Review 4.  Endocrinological aspects of HIV infection.

Authors:  F S Mirza; P Luthra; L Chirch
Journal:  J Endocrinol Invest       Date:  2018-01-08       Impact factor: 4.256

5.  Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: data from the Veterans Aging Cohort Study.

Authors:  Raj K Medapalli; Chirag R Parikh; Kirsha Gordon; Sheldon T Brown; Adeel A Butt; Cynthia L Gibert; David Rimland; Maria C Rodriguez-Barradas; Chung-Chou H Chang; Amy C Justice; John Cijiang He; Christina M Wyatt
Journal:  J Acquir Immune Defic Syndr       Date:  2012-08-01       Impact factor: 3.731

Review 6.  Hepatitis C Virus, Inflammation, and Cellular Aging: Turning Back Time.

Authors:  Susanna Naggie
Journal:  Top Antivir Med       Date:  2017 Feb/Mar

7.  Risk of liver decompensation with cumulative use of mitochondrial toxic nucleoside analogues in HIV/hepatitis C virus coinfection.

Authors:  Vincent Lo Re; Bret Zeldow; Michael J Kallan; Janet P Tate; Dena M Carbonari; Sean Hennessy; Jay R Kostman; Joseph K Lim; Matthew Bidwell Goetz; Robert Gross; Amy C Justice; Jason A Roy
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-07-19       Impact factor: 2.890

8.  DNA Methylation Markers of Type 2 Diabetes Mellitus Among Male Veterans With or Without Human Immunodeficiency Virus Infection.

Authors:  Raina Mathur; Qin Hui; Yunfeng Huang; Marta Gwinn; Kaku So-Armah; Matthew S Freiberg; Amy C Justice; Ke Xu; Vincent C Marconi; Yan V Sun
Journal:  J Infect Dis       Date:  2019-05-24       Impact factor: 5.226

9.  Association of Metabolic Syndrome and Oxidative DNA Damage in HIV/AIDS Patients.

Authors:  Vaishali Kolgiri; Vidya Nagar; Vinayak Patil
Journal:  Indian J Clin Biochem       Date:  2017-06-12

Review 10.  Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions.

Authors:  Emily C Williams; Judith A Hahn; Richard Saitz; Kendall Bryant; Marlene C Lira; Jeffrey H Samet
Journal:  Alcohol Clin Exp Res       Date:  2016-09-22       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.